Loss of the Non-Canonical BAF Complex as a Driver and Therapeutic Target in SF3B1-Mutant MDS and Leukemia IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-2024) Robert Bradley, PhD, Fred Hutchinson Cancer Research Center Read More
Clonal Evolution of Pre-Leukemic Hematopoietic Stem Cells in Human Myeloid Malignancies IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-2024) Ravi Majeti, MD, PhD, Stanford University School of Medicine Read More
Development and Application of a Pan-Cancer Diagnostic Test for Early Detection of Cancer Momentum Fellow (2020-2021) Dimitrios Mathios, MD, Johns Hopkins University School of Medicine Read More
Mechanisms of Tumor-Initiation in B-Lymphoid Malignancies IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-2024) Markus Müschen, MD, PhD, Yale University Read More
Characterizing a Novel RasGRP1-mTOR Pathway in Immune and Cancer Cells Momentum Fellow (2020-2022) Kriti Bahl, PhD, University of California, San Francisco Read More
In Vivo Generation of Chimeric Antigen Receptor Cells to Treat Hemopoietic Malignancies IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-2024) Ron Levy, MD, Stanford University School of Medicine Read More